Publication | Open Access

Metal–drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells

Trypanosoma CruziMedicinal ChemistryBiochemistryAntiparasitic AgentMedicineNatural SciencesParasitic ProtozoaAfrican TrypanosomiasisMetal–drug SynergyNew RutheniumPharmacologyVisceral LeishmaniasisDrug Discovery